Free Trial

Cadre (CDRE) Competitors

Cadre logo
$32.37 -0.70 (-2.12%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$32.34 -0.03 (-0.09%)
As of 08/1/2025 04:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CDRE vs. GKOS, BLCO, SLNO, IRTC, INSP, TMDX, NVST, PRCT, WRBY, and LIVN

Should you be buying Cadre stock or one of its competitors? The main competitors of Cadre include Glaukos (GKOS), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), Inspire Medical Systems (INSP), TransMedics Group (TMDX), Envista (NVST), PROCEPT BioRobotics (PRCT), Warby Parker (WRBY), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry.

Cadre vs. Its Competitors

Glaukos (NYSE:GKOS) and Cadre (NYSE:CDRE) are both medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership.

Cadre has a net margin of 6.87% compared to Glaukos' net margin of -21.43%. Cadre's return on equity of 12.52% beat Glaukos' return on equity.

Company Net Margins Return on Equity Return on Assets
Glaukos-21.43% -8.59% -6.61%
Cadre 6.87%12.52%6.04%

99.0% of Glaukos shares are owned by institutional investors. Comparatively, 44.0% of Cadre shares are owned by institutional investors. 5.8% of Glaukos shares are owned by company insiders. Comparatively, 37.0% of Cadre shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Glaukos has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500. Comparatively, Cadre has a beta of 1.31, suggesting that its share price is 31% more volatile than the S&P 500.

Glaukos presently has a consensus target price of $127.42, indicating a potential upside of 47.49%. Cadre has a consensus target price of $37.50, indicating a potential upside of 15.85%. Given Glaukos' stronger consensus rating and higher probable upside, equities analysts clearly believe Glaukos is more favorable than Cadre.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Glaukos
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.75
Cadre
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Cadre has higher revenue and earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Glaukos$383.48M12.87-$146.37M-$2.37-36.45
Cadre$567.56M2.32$36.13M$0.9534.07

In the previous week, Glaukos had 15 more articles in the media than Cadre. MarketBeat recorded 19 mentions for Glaukos and 4 mentions for Cadre. Cadre's average media sentiment score of 0.88 beat Glaukos' score of 0.77 indicating that Cadre is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Glaukos
7 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cadre
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Cadre beats Glaukos on 10 of the 16 factors compared between the two stocks.

Get Cadre News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDRE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDRE vs. The Competition

MetricCadrePROTECTION IndustryIndustrials SectorNYSE Exchange
Market Cap$1.34B$2.10B$7.61B$20.69B
Dividend Yield1.15%1.83%4.56%3.67%
P/E Ratio34.0741.9225.2229.07
Price / Sales2.323.4598.7866.55
Price / Cash23.3565.3627.7622.84
Price / Book4.228.864.344.43
Net Income$36.13M$110.42M$792.92M$994.22M
7 Day Performance-4.39%-6.13%-1.85%-3.35%
1 Month Performance1.53%-2.81%2.34%-2.06%
1 Year Performance-5.52%145.39%29.40%10.15%

Cadre Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDRE
Cadre
3.1289 of 5 stars
$32.37
-2.1%
$37.50
+15.8%
-9.5%$1.34B$567.56M34.072,284Upcoming Earnings
GKOS
Glaukos
3.9692 of 5 stars
$94.80
+0.5%
$134.67
+42.1%
-26.6%$5.39B$383.48M-40.00780Trending News
Earnings Report
Analyst Forecast
BLCO
Bausch + Lomb
2.7085 of 5 stars
$14.47
+1.0%
$15.45
+6.8%
-19.8%$5.07B$4.79B-14.0513,500News Coverage
Earnings Report
Analyst Forecast
SLNO
Soleno Therapeutics
4.2762 of 5 stars
$85.25
-1.4%
$108.70
+27.5%
+74.8%$4.36BN/A-18.4530Positive News
Upcoming Earnings
IRTC
iRhythm Technologies
1.7857 of 5 stars
$137.11
+2.2%
$137.30
+0.1%
+95.9%$4.28B$591.84M-43.672,000Trending News
Earnings Report
Analyst Forecast
Gap Up
INSP
Inspire Medical Systems
4.7194 of 5 stars
$130.72
+1.4%
$208.55
+59.5%
-13.1%$3.80B$802.80M60.241,246Positive News
Upcoming Earnings
TMDX
TransMedics Group
2.4919 of 5 stars
$105.24
-2.7%
$129.88
+23.4%
-20.4%$3.66B$441.54M77.38210Trending News
Earnings Report
Analyst Forecast
NVST
Envista
3.5735 of 5 stars
$20.73
-0.3%
$20.23
-2.4%
+22.7%$3.53B$2.51B-3.1712,300Trending News
Earnings Report
Analyst Forecast
PRCT
PROCEPT BioRobotics
2.6459 of 5 stars
$54.08
-2.9%
$84.13
+55.6%
-19.4%$3.08B$224.50M-31.81430Upcoming Earnings
WRBY
Warby Parker
2.087 of 5 stars
$24.10
-1.2%
$22.88
-5.1%
+48.9%$2.55B$771.32M-200.833,780News Coverage
Positive News
Upcoming Earnings
Analyst Forecast
Short Interest ↑
LIVN
LivaNova
2.9291 of 5 stars
$43.46
-0.5%
$59.29
+36.4%
-14.9%$2.38B$1.25B-10.632,900News Coverage
Positive News
Upcoming Earnings

Related Companies and Tools


This page (NYSE:CDRE) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners